Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Diabetes and associated disorders, and CAR-T cell therapy research.
FOXP3 expression depends on cell-type-specific cis-regulatory elements and transcription factor circuitry
Pharmacokinetics, lineage identity, and trafficking of ex vivo expanded polyclonal regulatory T cells in a prospective randomized clinical trial of kidney transplant recipients with allograft inflammation
CRISPR screens decode cancer cell pathways that trigger γδ T cell detection
CRISPR activation and interference screens decode stimulation responses in primary human T cells
Obesity alters pathology and treatment response in inflammatory disease
Selective decrease of donor-reactive T <sub>regs</sub> after liver transplantation limits T <sub>reg</sub> therapy for promoting allograft tolerance in humans
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes
Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance
IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function
The SIRPα–CD47 immune checkpoint in NK cells
Functional CRISPR dissection of gene networks controlling human regulatory T cell identity
Landscape of stimulation-responsive chromatin across diverse human immune cells
Mitigating Ischemic Injury of Stem Cell-Derived Insulin-Producing Cells after Transplant
Cutting Edge: Origins, Recruitment, and Regulation of CD11c+ Cells in Inflamed Islets of Autoimmune Diabetes Mice
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Attenuation of Donor-Reactive T Cells Allows Effective Control of Allograft Rejection Using Regulatory T Cell Therapy
IRE1α Induces Thioredoxin-Interacting Protein to Activate the NLRP3 Inflammasome and Promote Programmed Cell Death under Irremediable ER Stress